NewAmsterdam Pharma Company NV (NAMS) Q4 2025 Earnings

Nov 5Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.93
-0.67
-0.41
-0.15

Details

Expected EPS
-0.39095
Actual EPS
-0.61
Surprise EPS
-0.22
Surprise Percent
-56.03%

Description

⁨NewAmsterdam Pharma Company NV⁩ (⁦NAMS⁩) has reported earnings of ⁦-0.61⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts